Corticosteroid therapy for IgA nephropathy can improve renal outcomes Jacinthlyn Sylvia25 Jan 2024 6:00 AM ISTIn a recent study by Yu Wang and colleagues analyzed corticosteroid therapy as a potential treatment for IgA nephropathy (IgAN). This study published...
Retinal OCT may provide crucial insights into kidney injury Dr. Kamal Kant Kohli24 Jan 2024 1:15 AM ISTUK: A recent study published in Nature Communications has shown the potential of 3D eye scans to reveal vital clues about kidney health that could...
Proenkephalin as biomarker for acute renal injury - a systematic review Dr Monish Raut23 Jan 2024 11:45 AM ISTRecently published systematic review and meta-analysis aimed to investigate the correlation between Proenkephalin A 119-159 (PENK) levels and the...
Brief dialysis may be best for patients with acute kidney injury Dr. Kamal Kant Kohli22 Jan 2024 8:00 AM ISTPatients with acute kidney injury requiring outpatient dialysis after hospital discharge receive the same care as those with the more common end-stage...
Long-term PPI Use Increases the risk and recurrence of Kidney Stones Aditi20 Jan 2024 2:00 AM ISTPrevious studies have mentioned an association between Exposure to PPIs and an increased risk of kidney stones among GERD patients. Hypomagnesemia and...
Trazadone and CBT no more effective than placebo for improving insomnia among long-term dialysis patients Dr. Kamal Kant Kohli19 Jan 2024 7:30 PM ISTA clinical trial of more than 120 persons undergoing hemodialysis found that cognitive behavioral therapy for insomnia (CBT-I) or trazodone were no...
Sun Pharma gets non-exclusive rights to market second brand of Finerenone in India Ruchika Sharma19 Jan 2024 11:17 AM ISTBayer has granted the non-exclusive rights to Sun Pharma to market and distribute a second brand of Finerenone under the brand name Lyvelsa.
Sleep disturbance and depression linked to worse QoL among patients with OAB Aditi18 Jan 2024 8:30 PM ISTOveractive bladder (OAB) can have a negative impact on health-related quality of life (HRQoL) and treatment adherence, but the exact nature of their...
Psychosocial interventions lift depression and improve QoL among CKD patients with depression Dr. Shravani Dali17 Jan 2024 8:30 PM ISTPsychosocial interventions lift depression and improve QoL among CKD patients with depression suggests a new study published in the BMC...
Trazadone and CBT not effective than placebo for improving insomnia in dialysis patients Anshika Mishra17 Jan 2024 9:30 AM ISTA clinical trial of more than 120 persons undergoing hemodialysis found that cognitive behavioral therapy for insomnia (CBT-I) or trazodone were no...
Urease-powered nanorobots reduced bladder tumours by 90 per cent Dr. Kamal Kant Kohli16 Jan 2024 5:28 PM ISTSpain: A recent study published in the prestigious journal Nature Nanotechnology reveals how a research team successfully reduced the size of bladder...
Novel aldosterone synthase inhibitor with concurrent empagliflozin reduces albuminuria in CKD patients: Lancet Medha Baranwal16 Jan 2024 7:00 AM ISTUSA: A randomised, controlled, phase 2 trial published in The Lancet has shed light on the safety and efficacy of aldosterone synthase inhibition with...
